Over the last decade, technological advances have revolutionised efforts to understand the
role played by microbes in airways disease. With the application of ever more sophisticated …

Importance Macrolide antibiotics such as erythromycin may improve clinical outcomes in
non–cystic fibrosis (CF) bronchiectasis, although associated risks of macrolide resistance are …

Progressive loss of lung function resulting from the inflammatory response to bacterial
colonization is the leading cause of mortality in cystic fibrosis (CF) patients. A greater …

… David J Serisier1, … Correspondence to Dr David J Serisier, Department of Respiratory
Medicine, Level 9 Mater Adult Hospital, Raymond Tce, South Brisbane, QLD 4101, … Serisier DJ …

Background and Purpose— Severe atherosclerosis in the aortic arch is associated with a
high risk of recurrent vascular events, but the optimal antithrombotic strategy is unclear. …

Rationale: Although airway microbiota composition correlates with clinical measures in non–cystic
fibrosis bronchiectasis, these data are unlikely to provide useful prognostic …

Rationale Despite the potentially important roles for infection in adult non-cystic fibrosis (CF)
bronchiectasis disease progression, the bacterial species present in the lower airways of …

Background Long-term macrolide treatment has proven benefit in inflammatory airways
diseases, but whether it leads to changes in the composition of respiratory microbiota is unknown…

Macrolide antibiotics have established efficacy in the management of cystic fibrosis and diffuse
panbronchiolitis—uncommon lung diseases with substantial morbidity and the potential …

The bacterial communities present in the oral cavity and the lungs of 19 adult cystic fibrosis (CF)
patients were compared by using terminal restriction fragment length polymorphism …